Volatility Down, Stock Market Up: What Would Signal a True Correction?
Among the new concerns on investors' Wall of Worry is the crisis in Iraq and the troubling situation with corporate bonds.
Vertex's Price Pop by the Numbers: Does It Fly?
Shares of Vertex Pharmaceuticals rise 40% on positive test results
Lululemon: What's Founder Chip Wilson Up To?
Founder Chip Wilson tries to shake things up at Lululemon
Twitter Could Be Gunning to Hit New Highs
Twitter has long-term potential, but for now it makes sense to lock in some profits.
Jason Haver: Long Bond Captures Target; S&P Approaches Its Next Targets
The bond-target capture leaves that playing field open; meanwhile equities are approaching their next targets.
Why Hercules Offshore, Merrimack Pharmaceuticals, and Smith & Wesson Holdings Tumbled Today
Even though the stock market climbed to new heights, these stocks missed out. Find out why.
Twitter's Bet on Social Television: Is It Enough?
Twitter acquires television editing platform SnappyTV.
Record Stock Buybacks and Dividend Payouts Fuel Equity Markets
Almost $1 trillion in cash was pushed back into the equity market in the first quarter.